{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:54:04Z","timestamp":1784757244838,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["24AA2006"],"award-info":[{"award-number":["24AA2006"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j intensive care"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Corticosteroids improve the outcomes of severe pneumonia; however, the most effective type remains unknown. In this study, we compared the mortality rates of patients with severe pneumonia who were treated with methylprednisolone versus those treated with hydrocortisone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this retrospective observational study, we utilized a nationwide Japanese Diagnosis Procedure Combination inpatient database to include adult patients with severe pneumonia who were admitted to hospitals between April 2017 and March 2022 and received either methylprednisolone or hydrocortisone. Propensity score matching was used to adjust for measured confounders, with in-hospital mortality as the primary outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among the 5,084 eligible patients, 623 matched pairs were analyzed. In-hospital mortality rates were 23.9% in the hydrocortisone group and 19.4% in the methylprednisolone group (risk difference [RD], 4.5%; 95% confidence interval [CI] \u22120.082 to 9.1; p\u2009=\u20090.054). Subgroup analysis of patients with shock demonstrated significantly higher mortality in the hydrocortisone group than in the methylprednisolone group (44.7% versus 30.1%; RD, 14.6%; 95% CI 1.4\u201327.8; p\u2009=\u20090.031).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>No significant difference in in-hospital mortality was observed between patients with severe pneumonia treated with methylprednisolone and those treated with hydrocortisone. Nevertheless, patients experiencing severe pneumonia-induced septic shock may derive benefits from methylprednisolone treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40560-025-00810-1","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T06:23:04Z","timestamp":1752560584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mortality of severe pneumonia treated with methylprednisolone versus hydrocortisone: a propensity-matched analysis"],"prefix":"10.1186","volume":"13","author":[{"given":"Takuya","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sasabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Aso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"810_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9.","journal-title":"Lancet"},{"key":"810_CR2","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/CID\/CIX647","volume":"65","author":"JA Ramirez","year":"2017","unstructured":"Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, et al. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017;65:1806\u201312. https:\/\/doi.org\/10.1093\/CID\/CIX647.","journal-title":"Clin Infect Dis"},{"key":"810_CR3","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/S1473-3099(22)00510-2","volume":"22","author":"GBD 2019 LRI Collaborators","year":"2022","unstructured":"GBD 2019 LRI Collaborators. Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990\u20132019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis. 2022;22:1626\u201347. https:\/\/doi.org\/10.1016\/S1473-3099(22)00510-2.","journal-title":"Lancet Infect Dis"},{"key":"810_CR4","unstructured":"Ministry of Health, Labour and Welfare, Japan: Survey of medical institutions. 2020. https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/kanja\/20\/dl\/suikeikanjya.pdf. Accessed 24 June 2024."},{"key":"810_CR5","unstructured":"Ministry of Health, Labour and Welfare, Japan: vital statistics of Japan. 2022. https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/kakutei22\/dl\/15_all.pdf. Accessed June 24 2024."},{"key":"810_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","volume":"48","author":"GU Meduri","year":"2022","unstructured":"Meduri GU, Shih MC, Bridges L, Martin TJ, El-Solh A, Seam N, et al. Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med. 2022;48:1009\u201323. https:\/\/doi.org\/10.1007\/s00134-022-06684-3.","journal-title":"Intensive Care Med"},{"key":"810_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/JAMA.2015.88","volume":"313","author":"A Torres","year":"2015","unstructured":"Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313:677\u201386. https:\/\/doi.org\/10.1001\/JAMA.2015.88.","journal-title":"JAMA"},{"key":"810_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/CID\/CIX801","volume":"66","author":"M Briel","year":"2018","unstructured":"Briel M, Spoorenberg SMC, Snijders D, Torres A, Fernandez-Serrano S, Meduri GU, et al. Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data meta-analysis. Clin Infect Dis. 2018;66:346\u201354. https:\/\/doi.org\/10.1093\/CID\/CIX801.","journal-title":"Clin Infect Dis"},{"key":"810_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007720.PUB3","author":"A Stern","year":"2017","unstructured":"Stern A, Skalsky K, Avni T, Carrara E, Leibovici L, Paul M. Corticosteroids for pneumonia. Cochrane Database Syst Rev. 2017. https:\/\/doi.org\/10.1002\/14651858.CD007720.PUB3.","journal-title":"Cochrane Database Syst Rev"},{"key":"810_CR10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02535-2020","author":"E Wittermans","year":"2021","unstructured":"Wittermans E, Vestjens SMT, Spoorenberg SMC, Blok WL, Grutters JC, Janssen R, et al. Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial. Eur Respir J. 2021. https:\/\/doi.org\/10.1183\/13993003.02535-2020.","journal-title":"Eur Respir J"},{"key":"810_CR11","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"PF Dequin","year":"2023","unstructured":"Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, et al. Hydrocortisone in severe community-acquired pneumonia. N Engl J Med. 2023;388:1931\u201341. https:\/\/doi.org\/10.1056\/NEJMoa2215145.","journal-title":"N Engl J Med"},{"key":"810_CR12","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/CCM.0000000000006171","volume":"52","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena RS, et al. Executive summary: guidelines on use of corticosteroids in critically ill patients with sepsis, acute respiratory distress syndrome, and community-acquired pneumonia focused update 2024. Crit Care Med. 2024;52:833\u20136. https:\/\/doi.org\/10.1097\/CCM.0000000000006171.","journal-title":"Crit Care Med"},{"key":"810_CR13","doi-asserted-by":"publisher","first-page":"e954","DOI":"10.1097\/CCM.0000000000002462","volume":"45","author":"F Fadel","year":"2017","unstructured":"Fadel F, Andr\u00e9-Gr\u00e9goire G, Gravez B, Bauvois B, Bouchet S, Sierra-Ramos C, et al. Aldosterone and vascular mineralocorticoid receptors in murine endotoxic and human septic shock. Crit Care Med. 2017;45:e954\u201362. https:\/\/doi.org\/10.1097\/CCM.0000000000002462.","journal-title":"Crit Care Med"},{"key":"810_CR14","doi-asserted-by":"publisher","first-page":"E219","DOI":"10.1097\/CCM.0000000000006172","volume":"52","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena R, et al. 2024 Focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia. Crit Care Med. 2024;52:E219\u201333. https:\/\/doi.org\/10.1097\/CCM.0000000000006172.","journal-title":"Crit Care Med"},{"key":"810_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13054-017-1659-4\/FIGURES\/3","volume":"21","author":"B Gibbison","year":"2017","unstructured":"Gibbison B, L\u00f3pez-L\u00f3pez JA, Higgins JPT, Miller T, Angelini GD, Lightman SL, et al. Corticosteroids in septic shock: a systematic review and network meta-analysis. Crit Care. 2017;21:1\u20138. https:\/\/doi.org\/10.1186\/S13054-017-1659-4\/FIGURES\/3.","journal-title":"Crit Care"},{"key":"810_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.37737\/ace.1.3_76","volume":"1","author":"H Yasunaga","year":"2019","unstructured":"Yasunaga H. Real world data in Japan: chapter II the diagnosis procedure combination database. Ann Clin Epidemiol. 2019;1:76\u20139.","journal-title":"Ann Clin Epidemiol"},{"key":"810_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.37737\/ACE.24015","volume":"6","author":"H Yasunaga","year":"2024","unstructured":"Yasunaga H. Updated information on the diagnosis procedure combination data. Ann Clin Epidemiol. 2024;6:106\u201310. https:\/\/doi.org\/10.37737\/ACE.24015.","journal-title":"Ann Clin Epidemiol"},{"key":"810_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/J.1440-1843.2008.01329.X","volume":"13","author":"Y Shindo","year":"2008","unstructured":"Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Imaizumi K, et al. Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia. Respirology. 2008;13:731\u20135. https:\/\/doi.org\/10.1111\/J.1440-1843.2008.01329.X.","journal-title":"Respirology"},{"key":"810_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.je.2016.09.009","volume":"27","author":"H Yamana","year":"2017","unstructured":"Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27:476\u201382. https:\/\/doi.org\/10.1016\/j.je.2016.09.009.","journal-title":"J Epidemiol"},{"key":"810_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/AJE\/KWQ433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676\u201382. https:\/\/doi.org\/10.1093\/AJE\/KWQ433.","journal-title":"Am J Epidemiol"},{"key":"810_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1183\/09031936.00081514","volume":"45","author":"T Tagami","year":"2015","unstructured":"Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H. Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients. Eur Respir J. 2015;45:463\u201372. https:\/\/doi.org\/10.1183\/09031936.00081514.","journal-title":"Eur Respir J"},{"key":"810_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/09638288809164103","volume":"10","author":"C Collin","year":"1988","unstructured":"Collin C, Wade DT, Davies S, Horne V. The Barthel ADL index: a reliability study. Int Disabil Stud. 1988;10:61\u20133. https:\/\/doi.org\/10.3109\/09638288809164103.","journal-title":"Int Disabil Stud"},{"key":"810_CR23","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/ARCLIN\/ACW049","volume":"31","author":"ME Mlinac","year":"2016","unstructured":"Mlinac ME, Feng MC. Assessment of activities of daily living, self-care, and independence. Arch Clin Neuropsychol. 2016;31:506\u201316. https:\/\/doi.org\/10.1093\/ARCLIN\/ACW049.","journal-title":"Arch Clin Neuropsychol"},{"key":"810_CR24","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/J.GERINURSE.2024.10.016","volume":"60","author":"Y Yamaguchi","year":"2024","unstructured":"Yamaguchi Y, Greiner C, Nakamura M, Kabaya S. Caregiver burden and psychological status and their associations with sleep quality among family caregivers living with older people with dementia: a mixed method study. Geriatr Nurs (Minneap). 2024;60:504\u201310. https:\/\/doi.org\/10.1016\/J.GERINURSE.2024.10.016.","journal-title":"Geriatr Nurs (Minneap)"},{"key":"810_CR25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/J.1532-5415.2005.53175.X","volume":"53","author":"T Tsutsui","year":"2005","unstructured":"Tsutsui T, Muramatsu N. Care-needs certification in the long-term care insurance system of Japan. J Am Geriatr Soc. 2005;53:522\u20137. https:\/\/doi.org\/10.1111\/J.1532-5415.2005.53175.X.","journal-title":"J Am Geriatr Soc"},{"key":"810_CR26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CCM.0000000000005822","volume":"51","author":"H Ohbe","year":"2023","unstructured":"Ohbe H, Ouchi K, Miyamoto Y, Ishigami Y, Matsui H, Yasunaga H, et al. One-year functional outcomes after invasive mechanical ventilation for older adults with preexisting long-term care-needs. Crit Care Med. 2023;51:584. https:\/\/doi.org\/10.1097\/CCM.0000000000005822.","journal-title":"Crit Care Med"},{"key":"810_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2188\/JEA.JE20220147","volume":"33","author":"M Nakajima","year":"2023","unstructured":"Nakajima M, Okada Y, Sonoo T, Goto T. Development and validation of a novel method for converting the Japan Coma Scale to Glasgow Coma Scale. J Epidemiol. 2023;33:531. https:\/\/doi.org\/10.2188\/JEA.JE20220147.","journal-title":"J Epidemiol"},{"key":"810_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2176\/NMC.47.291","volume":"47","author":"K Ono","year":"2007","unstructured":"Ono K, Wada K, Takahara T, Shirotani T. Indications for computed tomography in patients with mild head injury. Neurol Med Chir (Tokyo). 2007;47:291\u20138. https:\/\/doi.org\/10.2176\/NMC.47.291.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"810_CR29","doi-asserted-by":"publisher","first-page":"e002736","DOI":"10.1136\/BMJOPEN-2013-002736","volume":"3","author":"K Shigematsu","year":"2013","unstructured":"Shigematsu K, Nakano H, Watanabe Y. The eye response test alone is sufficient to predict stroke outcome\u2014reintroduction of Japan Coma Scale: a cohort study. BMJ Open. 2013;3:e002736. https:\/\/doi.org\/10.1136\/BMJOPEN-2013-002736.","journal-title":"BMJ Open"},{"key":"810_CR30","volume-title":"Goodman & Gilman\u2019s: the pharmacological basis of therapeutics","year":"2018","unstructured":"Brunton LL, Knollmann BC, Hilal-Dandan R, editors. Goodman & Gilman\u2019s: the pharmacological basis of therapeutics. 14th ed. New York: McGraw-Hill Education; 2018.","edition":"14"},{"key":"810_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","volume":"39","author":"PR Rosenbaum","year":"1985","unstructured":"Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33\u20138. https:\/\/doi.org\/10.1080\/00031305.1985.10479383.","journal-title":"Am Stat"},{"key":"810_CR32","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/AJE\/KWY049","volume":"187","author":"SV Wang","year":"2018","unstructured":"Wang SV, Jin Y, Fireman B, Gruber S, He M, Wyss R, et al. Relative performance of propensity score matching strategies for subgroup analyses. Am J Epidemiol. 2018;187:1799\u2013807. https:\/\/doi.org\/10.1093\/AJE\/KWY049.","journal-title":"Am J Epidemiol"},{"key":"810_CR33","doi-asserted-by":"publisher","first-page":"100116","DOI":"10.1016\/J.GLOEPI.2023.100116","volume":"6","author":"M Morsali","year":"2023","unstructured":"Morsali M, Doosti-Irani A, Amini S, Nazemipour M, Mansournia MA, Aliannejad R. Comparison of corticosteroids types, dexamethasone, and methylprednisolone in patients hospitalized with COVID-19: a systematic review and network meta-analysis. Glob Epidemiol. 2023;6:100116. https:\/\/doi.org\/10.1016\/J.GLOEPI.2023.100116.","journal-title":"Glob Epidemiol"},{"key":"810_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s10354-022-00993-4","volume":"173","author":"A Taher","year":"2023","unstructured":"Taher A, Lashkari M, Keramat F, Hashemi SH, Sedighi L, Poorolajal J, et al. Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial. Wien Med Wochenschr. 2023;173:140\u201351. https:\/\/doi.org\/10.1007\/s10354-022-00993-4.","journal-title":"Wien Med Wochenschr"},{"key":"810_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/J.RESINV.2024.12.014","volume":"63","author":"A Ueda","year":"2025","unstructured":"Ueda A, Nohara K. Impact of COVID-19 pandemic on pneumonia trends in Japan: insights from diagnosis procedure combination data. Respir Investig. 2025;63:170\u20133. https:\/\/doi.org\/10.1016\/J.RESINV.2024.12.014.","journal-title":"Respir Investig"},{"key":"810_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000335466","volume":"85","author":"S Kohno","year":"2012","unstructured":"Kohno S, Seki M, Takehara K, Yamada Y, Kubo K, Ishizaka A, et al. Prediction of requirement for mechanical ventilation in community-acquired pneumonia with acute respiratory failure: a multicenter prospective study. Respiration. 2012;85:27\u201335. https:\/\/doi.org\/10.1159\/000335466.","journal-title":"Respiration"},{"key":"810_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJM199701233360402","volume":"336","author":"MJ Fine","year":"1997","unstructured":"Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243\u201350. https:\/\/doi.org\/10.1056\/NEJM199701233360402.","journal-title":"N Engl J Med"},{"issue":"4","key":"810_CR38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/J.AMJMED.2005.01.006","volume":"118","author":"D Aujesky","year":"2005","unstructured":"Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005;118(4):384\u201392. https:\/\/doi.org\/10.1016\/J.AMJMED.2005.01.006.","journal-title":"Am J Med"},{"issue":"5","key":"810_CR39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/THORAX.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377\u201382. https:\/\/doi.org\/10.1136\/THORAX.58.5.377.","journal-title":"Thorax"},{"key":"810_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1183\/09031936.06.00062505","volume":"27","author":"A Capelastegui","year":"2006","unstructured":"Capelastegui A, Espa\u00f1a PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J. 2006;27:151\u20137. https:\/\/doi.org\/10.1183\/09031936.06.00062505.","journal-title":"Eur Respir J"}],"container-title":["Journal of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-025-00810-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40560-025-00810-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-025-00810-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:01:06Z","timestamp":1757239266000},"score":1,"resource":{"primary":{"URL":"https:\/\/jintensivecare.biomedcentral.com\/articles\/10.1186\/s40560-025-00810-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["810"],"URL":"https:\/\/doi.org\/10.1186\/s40560-025-00810-1","relation":{},"ISSN":["2052-0492"],"issn-type":[{"value":"2052-0492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the University of Tokyo (approval number: 3501-5; May 19, 2021) for clinical epidemiological studies using DPC data. Given the unidentified nature of the data, the requirement for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Given the unidentified nature of the data, the requirement for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}